OTCMKTS:GRRMF

Gerresheimer (GRRMF) Stock Price, News & Analysis

$105.35
0.00 (0.00%)
(As of 04/24/2024 ET)
Today's Range
$105.35
$105.35
50-Day Range
$97.04
$117.47
52-Week Range
$91.00
$130.00
Volume
N/A
Average Volume
400 shs
Market Capitalization
N/A
P/E Ratio
46.41
Dividend Yield
0.49%
Price Target
N/A
GRRMF stock logo

About Gerresheimer Stock (OTCMKTS:GRRMF)

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

GRRMF Stock Price History

GRRMF Stock News Headlines

EQS-News: Gerresheimer makes solid start to the financial year 2024
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
International Companies Drive Diabesity Innovation
The "Smart Money" Is Ready for May 1st Are You?
Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.
Gerresheimer price target raised by EUR 5 at Barclays
Gerresheimer Signs Long-term Electricity Supply Deal With PNE AG
Gerresheimer AG Q4 adjusted EBITDA up Y/Y
EQS-DD: Gerresheimer AG english
See More Headlines
Receive GRRMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gerresheimer and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:GRRMF
CIK
N/A
Fax
N/A
Employees
11,947
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Dietmar Siemssen (Age 61)
    CEO, Chairman of the Management Board and CEO of Plastics, Devices & Advanced Technologies Division
    Comp: $2.31M
  • Dr. Bernd Metzner Ph.D. (Age 54)
    CFO & Member of the Management Board
    Comp: $1.39M
  • Dr. Lukas Burkhardt (Age 45)
    Member of the Management Board
    Comp: $1.36M
  • Ms. Katja Schnitzler (Age 43)
    Global Senior VP of People & Organization and Member of Supervisory Board
    Comp: $114.95k
  • Mr. Guido Pickert
    Head of Investor Relations
  • Ueli Utzinger
    Group Senior Director Marketing & Communication
  • Ms. Carolin Nadilo
    Corporate Director of Investor Relations

GRRMF Stock Analysis - Frequently Asked Questions

Should I buy or sell Gerresheimer stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Gerresheimer in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" GRRMF shares.
View GRRMF analyst ratings
or view top-rated stocks.

How have GRRMF shares performed in 2024?

Gerresheimer's stock was trading at $102.60 at the beginning of 2024. Since then, GRRMF shares have increased by 2.7% and is now trading at $105.35.
View the best growth stocks for 2024 here
.

Are investors shorting Gerresheimer?

Gerresheimer saw a increase in short interest in March. As of March 31st, there was short interest totaling 204,000 shares, an increase of 29.3% from the March 15th total of 157,800 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 2,040.0 days.
View Gerresheimer's Short Interest
.

Is Gerresheimer a good dividend stock?

Gerresheimer (OTCMKTS:GRRMF) pays an annual dividend of $0.52 per share and currently has a dividend yield of 1.30%. The dividend payout ratio is 22.82%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Gerresheimer?

Shares of GRRMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:GRRMF) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners